Societe Generale’s Prothena Corp PRTA Stock Holding History

Societe Generale’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$111K	Buy	+3,164	New	+$138K	﹤0.01%	2348

Other funds holding PRTA

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Societe Generale's PRTA Position: Q2 2016 in Review

Societe Generale opened a new position in Prothena Corp (PRTA) in Q2 2016: 3,164 shares worth $111K. The stake represents ﹤0.01% of the portfolio and ranks #2348 among its holdings.

144 funds tracked by Wall St. Rank hold PRTA as of Q2 2016.

Societe Generale held 3,164 shares of Prothena Corp worth $111K as of Q2 2016.
Prothena Corp was a new Societe Generale position in Q2 2016.
Prothena Corp made up ﹤0.01% of Societe Generale's portfolio in Q2 2016, its #2348 holding.
144 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.